The Unseen Burden: Incidence and Outcomes of Infections in Leukemia
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Infectious Agents and Cancer".
Deadline for manuscript submissions: 31 August 2026 | Viewed by 939
Special Issue Editors
Interests: acute myeloid leukemia; acute lymphoblastic leukemia; infections; hematologic diseases
Interests: acute lymphoblastic leukemia; acute myeloid leukemia; flow cytometry
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Infections remain a leading cause of morbidity and mortality in patients with acute leukemia, profoundly impacting treatment outcomes and quality of life. Clinicians face a formidable challenge as they navigate the evolving landscape of new target therapeutic strategies, which is complicated by the rise of multidrug-resistant pathogens.
This Special Issue aims to provide a comprehensive and timely overview of the complex landscape of infectious complications in patients with acute leukemia. We aim to explore key areas, from a deeper understanding of the host–microbe interactions that shape infection risk to the impact of new therapeutic regimens on immune homeostasis and infection risk. We also hope to expand scientific knowledge about advances in diagnostic and therapeutic strategies, offering critical insights to optimize patient management and improve survival. This collection serves as a vital resource for hematologists and infectious disease specialists, highlighting the persistent threat of infections and guiding the way toward a safer, more effective approach to leukemia care.
Dr. Elisa Buzzatti
Dr. Maria Ilaria Del Principe
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- infection management
- infectious risk
- antimicrobial therapy
- antimicrobial prophylaxis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
